Literature DB >> 12020261

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease.

Eva Hogervorst1, Helen Mendes Ribeiro, Andrew Molyneux, Marc Budge, A David Smith.   

Abstract

CONTEXT: The pathogenesis of leukoaraiosis on computed tomographic (CT) scanning is unknown, but cerebrovascular risk factors for leukoaraiosis show overlap with those for Alzheimer disease (AD).
OBJECTIVE: To investigate the contribution of cerebrovascular risk factors, in particular plasma total homocysteine (tHcy), to leukoaraiosis in patients with AD and controls.
DESIGN: Cross-sectional case-control study.
SETTING: Referral population to a hospital clinic and community volunteers from the Oxfordshire region in England seen between July 1, 1988, and July 1, 2000. PARTICIPANTS: One hundred thirty-seven AD cases (104 confirmed post mortem) and 277 controls matched for age (mean +/- SD, 73 +/- 8 years) and sex. MAIN OUTCOME MEASURES: Cerebrovascular risk factors and leukoaraiosis on CT scans of cases and controls; the odds ratio (OR) of having moderate to severe leukoaraiosis with higher levels of plasma tHcy and cerebrovascular risk factors such as age, sex, systolic blood pressure, smoking, diabetes mellitus, and apolipoprotein E epsilon4 genotype.
RESULTS: Leukoaraiosis was more prevalent in AD cases. For a 5-micromol/L increase in tHcy levels, the OR for leukoaraiosis was 1.40 (95% confidence interval, 1.02-1.91) independent of other risk factors. The distribution pattern of leukoaraiosis was more marked in the deep white matter than in the periventricular area in individuals with elevated tHcy levels, particularly in patients with AD.
CONCLUSIONS: Higher tHcy levels are an independent risk factor for moderate to severe leukoaraiosis in individuals with AD and of leukoaraiosis of the deep white matter in particular. The nature of the relationship between tHcy levels and leukoaraiosis in AD requires further longitudinal and intervention studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020261     DOI: 10.1001/archneur.59.5.787

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  37 in total

1.  Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

Authors:  Adam M Brickman; Laura B Zahodne; Vanessa A Guzman; Atul Narkhede; Irene B Meier; Erica Y Griffith; Frank A Provenzano; Nicole Schupf; Jennifer J Manly; Yaakov Stern; José A Luchsinger; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2014-07-21       Impact factor: 4.673

2.  Meta-analysis of plasma homocysteine content and cognitive function in elderly patients with Alzheimer's disease and vascular dementia.

Authors:  Beiyun Wang; Yuan Zhong; Hong Yan; Liang Cui
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research.

Authors:  Richard S Beard; Shawn E Bearden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

4.  Construction of periventricular white matter hyperintensity maps by spatial normalization of the lateral ventricles.

Authors:  Cynthia Jongen; Jeroen van der Grond; Petronella Anbeek; Max A Viergever; Geert Jan Biessels; Josien P W Pluim
Journal:  Hum Brain Mapp       Date:  2009-07       Impact factor: 5.038

5.  Increased ER stress as a mechanism of retinal neurovasculopathy in mice with severe hyperhomocysteinemia.

Authors:  Amany Tawfik; Sylvia B Smith
Journal:  Austin J Clin Ophthalmol       Date:  2014-06-16

6.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

Review 7.  Vascular pathology in the aged human brain.

Authors:  Lea Tenenholz Grinberg; Dietmar Rudolf Thal
Journal:  Acta Neuropathol       Date:  2010-02-14       Impact factor: 17.088

8.  One-carbon metabolism and Alzheimer's disease: focus on epigenetics.

Authors:  Fabio Coppedè
Journal:  Curr Genomics       Date:  2010-06       Impact factor: 2.236

9.  Total homocysteine and cognition in a tri-ethnic cohort: the Northern Manhattan Study.

Authors:  C B Wright; H-S Lee; M C Paik; S P Stabler; R H Allen; R L Sacco
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

10.  Plasma Total Homocysteine Levels are not Associated with Medial Temporal Lobe Atrophy, but with White Matter Changes in Alzheimer's Disease.

Authors:  Sung Rae Kim; Seong Hye Choi; Choong Kun Ha; Shin Goo Park; Hae Wook Pyun; Dae Hyun Yoon
Journal:  J Clin Neurol       Date:  2009-06-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.